Clinical trial
A Single Dose PK Study of BTDS 5, 10, and 20 in Chinese Osteoarthritis Patients
NCT01643759 is registered in ClinicalTrials.gov with Mundipharma (China) Pharmaceutical Co. Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Dose PK Study of BTDS 5, 10, and 20 in Chinese Osteoarthritis Patients
- Lead sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- Not reported
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis disorders